Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
methylprednisolonnatriumsuccinat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 125 mg/2 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 40 mg/ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 40 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 125 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 1 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 500 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 2 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 125 mg injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
|
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone sodium succinate (substance) |
Inferred relationship |
Some |
1 |